Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Entrada Therapeutics (NASDAQ:TRDA) through any online brokerage.
Other companies in Entrada Therapeutics’s space includes: 4D Molecular Therapeutics Inc (NASDAQ:FDMT), Upstream Bio Inc (NASDAQ:UPB), Altimmune Inc (NASDAQ:ALT), ADC Therapeutics SA (NYSE:ADCT) and Prothena Corp PLC (NASDAQ:PRTA).
Entrada Therapeutics has a consensus price target of $23.80.
The stock price for Entrada Therapeutics (NASDAQ: TRDA) is $11.98 last updated March 19, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Entrada Therapeutics.
Entrada Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Entrada Therapeutics.
Entrada Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.